- Home
- LCTX vs MCTR Comparison
LCTX vs MCTR Comparison
Compare LCTX & MCTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCTX
- MCTR
- Stock Information
- Founded
- LCTX 1990
- MCTR 2014
- Country
- LCTX United States
- MCTR Hong Kong
- Employees
- LCTX N/A
- MCTR N/A
- Industry
- LCTX Biotechnology: Biological Products (No Diagnostic Substances)
- MCTR
- Sector
- LCTX Health Care
- MCTR
- Exchange
- LCTX Nasdaq
- MCTR NYSE
- Market Cap
- LCTX 107.3M
- MCTR 41.0M
- IPO Year
- LCTX N/A
- MCTR 2025
- Fundamental
- Price
- LCTX $1.03
- MCTR $2.22
- Analyst Decision
- LCTX Strong Buy
- MCTR
- Analyst Count
- LCTX 5
- MCTR 0
- Target Price
- LCTX $4.20
- MCTR N/A
- AVG Volume (30 Days)
- LCTX 1.6M
- MCTR 135.5K
- Earning Date
- LCTX 08-07-2025
- MCTR 01-01-0001
- Dividend Yield
- LCTX N/A
- MCTR N/A
- EPS Growth
- LCTX N/A
- MCTR N/A
- EPS
- LCTX N/A
- MCTR 0.00
- Revenue
- LCTX $9,557,000.00
- MCTR $4,453,234.00
- Revenue This Year
- LCTX N/A
- MCTR N/A
- Revenue Next Year
- LCTX $232.66
- MCTR N/A
- P/E Ratio
- LCTX N/A
- MCTR $2,014.72
- Revenue Growth
- LCTX 19.42
- MCTR N/A
- 52 Week Low
- LCTX $0.37
- MCTR $2.31
- 52 Week High
- LCTX $1.21
- MCTR $54.91
- Technical
- Relative Strength Index (RSI)
- LCTX 53.25
- MCTR N/A
- Support Level
- LCTX $0.93
- MCTR N/A
- Resistance Level
- LCTX $1.02
- MCTR N/A
- Average True Range (ATR)
- LCTX 0.08
- MCTR 0.00
- MACD
- LCTX -0.01
- MCTR 0.00
- Stochastic Oscillator
- LCTX 35.71
- MCTR 0.00
About LCTX Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.
About MCTR CTRL GROUP LTD
CTRL Group Ltd is an integrated marketing and advertising services provider in Hong Kong specializing in mobile games promotion for the local market. It provide services to mobile game developers, principally developers of mobile gaming applications or apps that gamers download from the developers' websites and applicable mobile operating systems, such as Apple Store or Android Google Play Store.